|
Vaccine Detail
HIV DNA vaccine VlJns-tPA-gp120 |
Vaccine Information |
- Vaccine Name: HIV DNA vaccine VlJns-tPA-gp120
- Target Pathogen: Human Immunodeficiency Virus
- Target Disease: Acquired Immunodeficiency Syndrome (AIDS)
- Vaccine Ontology ID: VO_0004351
- Type: DNA vaccine
- Status: Research
- Host Species as Laboratory Animal Model: Rhesus monkey
- gp120
gene engineering:
- Type: DNA vaccine construction
- Description: This vaccine encoded gp120 from HIV IIIB (Lekutis et al., 1997).
- Detailed Gene Information: Click Here.
- DNA vaccine plasmid:
- DNA vaccine plasmid name:
- DNA vaccine plasmid VO ID: VO_0005044
- Immunization Route: Intramuscular injection (i.m.)
|
Host Response |
Monkey Response
- Vaccine Immune Response Type: VO_0000286
- Immune Response: The secretion of IFN-y stimulated CD4+ Th cell lines and rgp120-stimulated PBL from the vaccinated monkeys suggest that an HIV-1 env plasmid DNA vaccine elicits a Thl-like immune response in primates as well as in rodents (Lekutis et al., 1997)
- Efficacy: The secondary immune response that arose after repeated plasmid DNA administration was Thl-like, suggesting that the nature of the DNA vaccine-elicited Th cell response was maturation dependent. Evidence from vaccinated nonhuman primates suggests that a vigorous Th cell response, including viral Ag-specific IFN-y production, may be a correlate of protection from HIV- 1 and Simian Human Immunodeficiency Virus infection (Lekutis et al., 1997)
|
References |
Lekutis et al., 1997: Lekutis C, Shiver JW, Liu MA, Letvin NL. HIV-1 env DNA vaccine administered to rhesus monkeys elicits MHC class II-restricted CD4+ T helper cells that secrete IFN-gamma and TNF-alpha. Journal of immunology (Baltimore, Md. : 1950). 1997; 158(9); 4471-4477. [PubMed: 9127013].
|
|